{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T14:31:16Z","timestamp":1789050676952,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Zhejiang Provincial Natural Science Foundation of China","award":["LY16H280005"],"award-info":[{"award-number":["LY16H280005"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673623"],"award-info":[{"award-number":["81673623"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"\u201cXin Miao\u201d Student Research Program of Zhejiang Province","award":["2015R410052"],"award-info":[{"award-number":["2015R410052"]}]},{"DOI":"10.13039\/501100004863","name":"Zhejiang Chinese Medical University","doi-asserted-by":"publisher","award":["2015ZG03"],"award-info":[{"award-number":["2015ZG03"]}],"id":[{"id":"10.13039\/501100004863","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/j.lfs.2017.01.004","type":"journal-article","created":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T08:16:14Z","timestamp":1484208974000},"page":"45-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["Treatment of rheumatoid arthritis with combination of methotrexate and Tripterygium wilfordii: A meta-analysis"],"prefix":"10.1016","volume":"171","author":[{"given":"Xiaoyu","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunyun","family":"Zu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huawei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengping","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0033-525X","authenticated-orcid":false,"given":"Zhenghao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9746","key":"10.1016\/j.lfs.2017.01.004_bb0005","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S0140-6736(10)60826-4","article-title":"Rheumatoid arthritis","volume":"376","author":"Scott","year":"2010","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.lfs.2017.01.004_bb0010","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"issue":"3","key":"10.1016\/j.lfs.2017.01.004_bb0015","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.molmed.2016.01.005","article-title":"Novel immunotherapeutic avenues for rheumatoid arthritis","volume":"22","author":"Semerano","year":"2016","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.lfs.2017.01.004_bb0020","article-title":"Methotrexate for rheumatoid arthritis","volume":"2","author":"Suarez-Almazor","year":"2000","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.lfs.2017.01.004_bb0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2015.10.003","article-title":"Treatment of rheumatoid arthritis: unraveling the conundrum","volume":"65","author":"Zampeli","year":"2015","journal-title":"J. Autoimmun."},{"issue":"7","key":"10.1016\/j.lfs.2017.01.004_bb0030","first-page":"405","article-title":"Tripterygium wilfordii Hook f in rheumatoid arthritis and ankylosing spondylitis. Preliminary report","volume":"94","author":"Guo","year":"1981","journal-title":"Chin. Med. J."},{"issue":"7","key":"10.1016\/j.lfs.2017.01.004_bb0035","first-page":"399","article-title":"A double-blind study of T2 (tablets of polyglycosides of Tripterygium wilfodii hook) in the treatment of rheumatoid arthritis [in Chinese]","volume":"26","author":"Tao","year":"1987","journal-title":"Zhonghua Nei Ke Za Zhi"},{"issue":"3","key":"10.1016\/j.lfs.2017.01.004_bb0040","first-page":"465","article-title":"A randomized double blind, placebo controlled trial of topical Tripterygium wilfordii in rheumatoid arthritis: reanalysis using logistic regression analysis","volume":"30","author":"Cibere","year":"2003","journal-title":"J. Rheumatol."},{"issue":"9","key":"10.1016\/j.lfs.2017.01.004_bb0045","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/aps.2012.108","article-title":"Immunosuppressant discovery from Tripterygium wilfordii Hook f: the novel triptolide analog (5R)-5-hydroxytriptolide (LLDT-8)","volume":"33","author":"Tang","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.lfs.2017.01.004_bb0050","doi-asserted-by":"crossref","first-page":"9700","DOI":"10.1038\/srep09700","article-title":"Predicting and verifying outcome of Tripterygium wilfordii Hook F. based therapy in rheumatoid arthritis: from open to double-blinded randomized trial","volume":"5","author":"Jiang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2017.01.004_bb0055","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12906-016-1194-x","article-title":"Tripterygium wilfordii Hook F versus conventional synthetic disease-modifying anti-rheumatic drugs as monotherapy for rheumatoid arthritis: a systematic review and network meta-analysis","volume":"16","author":"Wang","year":"2016","journal-title":"BMC Complement. Altern. Med."},{"key":"10.1016\/j.lfs.2017.01.004_bb0060","doi-asserted-by":"crossref","first-page":"410793","DOI":"10.1155\/2013\/410793","article-title":"Extracts of Tripterygium wilfordii Hook F in the treatment of rheumatoid arthritis: a systemic review and meta-analysis of randomised controlled trials","volume":"2013","author":"Liu","year":"2013","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"4","key":"10.1016\/j.lfs.2017.01.004_bb0065","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/0003-4819-151-4-200908180-00005","article-title":"Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial","volume":"151","author":"Goldbach-Mansky","year":"2009","journal-title":"Ann. Intern. Med."},{"issue":"7","key":"10.1016\/j.lfs.2017.01.004_bb0070","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1002\/art.10411","article-title":"Benefit of an extract of Tripterygium wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study","volume":"46","author":"Tao","year":"2002","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.lfs.2017.01.004_bb0075","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1136\/annrheumdis-2013-204807","article-title":"Comparison of Tripterygium wilfordii Hook F with methotrexate in the treatment of active rheumatoid arthritis (TRIFRA): a randomised, controlled clinical trial","volume":"74","author":"Lv","year":"2015","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.lfs.2017.01.004_bb0080","first-page":"602","article-title":"Clinical investigation of Tripterygium glycosides plus methotrexate for treatment of rheumatoid arthritis [in Chinese]","volume":"z2","author":"Zhang","year":"2012","journal-title":"Chin. J. Med. Guide"},{"issue":"8","key":"10.1016\/j.lfs.2017.01.004_bb0085","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1097\/RHU.0b013e3181fe8ad1","article-title":"The safety and effectiveness of a chloroform\/methanol extract of Tripterygium wilfordii Hook F (T2) plus methotrexate in treating rheumatoid arthritis","volume":"16","author":"Zhang","year":"2010","journal-title":"J. Clin. Rheumatol."},{"issue":"12","key":"10.1016\/j.lfs.2017.01.004_bb0090","first-page":"895","article-title":"Clinical observation on small doses Tripterygium wilfordii polyglycoside combined with methotrexate in treating rheumatoid arthritis [in Chinese]","volume":"21","author":"Wu","year":"2001","journal-title":"Chin. J. Integr. Tradit. West. Med."},{"issue":"7","key":"10.1016\/j.lfs.2017.01.004_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.lfs.2017.01.004_bb0100","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.eplepsyres.2016.01.001","article-title":"The efficacy and safety of rufinamide in drug-resistant epilepsy: a meta-analysis of double-blind, randomized, placebo controlled trials","volume":"120","author":"Xu","year":"2016","journal-title":"Epilepsy Res."},{"issue":"3","key":"10.1016\/j.lfs.2017.01.004_bb0105","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1159\/000051263","article-title":"Interrater reliability of the modified Jadad quality scale for systematic reviews of Alzheimer's disease drug trials","volume":"12","author":"Oremus","year":"2001","journal-title":"Dement. Geriatr. Cogn. Disord."},{"issue":"6","key":"10.1016\/j.lfs.2017.01.004_bb0110","first-page":"334","article-title":"Clinical observation on the treatment of rheumatoid arthritis with Tripterygium glycosides and low dosage methopterin [in Chinese]","volume":"12","author":"Shen","year":"2002","journal-title":"Zhejiang J. Integr. Tradit. Chin. West. Med."},{"issue":"9","key":"10.1016\/j.lfs.2017.01.004_bb0115","first-page":"7","article-title":"Clinical evaluation of Tripterygium wilfordii polyglycosidium combined with methotrexate in treating rheumatoid arthritis and its effect on TNF-\u03b1 and IL-6 [in Chinese]","volume":"17","author":"Tan","year":"2010","journal-title":"Chin. J. Inf. Tradit. Chin. Med."},{"issue":"17","key":"10.1016\/j.lfs.2017.01.004_bb0120","first-page":"300","article-title":"Clinical observation on treatment of rheumatoid arthritis with Tripterygium wilfordii polyglycoside combined with methotrexate [in Chinese]","volume":"19","author":"Yang","year":"2013","journal-title":"Chin. J. Exp. Tradit. Med. Formulae"},{"issue":"11","key":"10.1016\/j.lfs.2017.01.004_bb0125","first-page":"1678","article-title":"Invistagtion of the effcaciou of the cobination of Tripterygium wilfordii with methotrexate treatmet on the rheumatoid arthritis [in Chinese]","volume":"20","author":"Wang","year":"2013","journal-title":"Chin. J. Prim. Med. Pharm."},{"issue":"17","key":"10.1016\/j.lfs.2017.01.004_bb0130","first-page":"2598","article-title":"Clinical observation on the treatment of rheumatoid arthritis with Tripterygium glycosides and methotrexate [in Chinese]","volume":"21","author":"Wang","year":"2015","journal-title":"Int. Med. Health Guid. News"},{"key":"10.1016\/j.lfs.2017.01.004_bb0135","doi-asserted-by":"crossref","first-page":"22602","DOI":"10.1038\/srep22602","article-title":"Deciphering the potential pharmaceutical mechanism of Chinese traditional medicine (Gui-Zhi-Shao-Yao-Zhi-Mu) on rheumatoid arthritis","volume":"6","author":"Huang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2017.01.004_bb0140","doi-asserted-by":"crossref","first-page":"16401","DOI":"10.1038\/srep16401","article-title":"A systems biology-based investigation into the pharmacological mechanisms of sheng-ma-bie-jia-tang acting on systemic lupus erythematosus by multi-level data integration","volume":"5","author":"Huang","year":"2015","journal-title":"Sci. Rep."},{"issue":"Database issue","key":"10.1016\/j.lfs.2017.01.004_bb0145","first-page":"D684","article-title":"STITCH: interaction networks of chemicals and proteins","volume":"36","author":"Kuhn","year":"2008","journal-title":"Nucleic Acids Res."},{"issue":"Database issue","key":"10.1016\/j.lfs.2017.01.004_bb0150","doi-asserted-by":"crossref","first-page":"D1091","DOI":"10.1093\/nar\/gkt1068","article-title":"DrugBank 4.0: shedding new light on drug metabolism","volume":"42","author":"Law","year":"2014","journal-title":"Nucleic Acids Res."},{"issue":"D1","key":"10.1016\/j.lfs.2017.01.004_bb0155","doi-asserted-by":"crossref","first-page":"D1069","DOI":"10.1093\/nar\/gkv1230","article-title":"Therapeutic target database update 2016: enriched resource for bench to clinical drug target and targeted pathway information","volume":"44","author":"Yang","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"3","key":"10.1016\/j.lfs.2017.01.004_bb0160","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nchembio.522","article-title":"XPB, a subunit of TFIIH, is a target of the natural product triptolide","volume":"7","author":"Titov","year":"2011","journal-title":"Nat. Chem. Biol."},{"issue":"3","key":"10.1016\/j.lfs.2017.01.004_bb0165","first-page":"267","article-title":"Triptolide induces anti-inflammatory cellular responses","volume":"1","author":"Matta","year":"2009","journal-title":"Am. J. Transl. Res."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320517300048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320517300048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,24]],"date-time":"2022-06-24T05:36:54Z","timestamp":1656049014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320517300048"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":33,"alternative-id":["S0024320517300048"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2017.01.004","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of rheumatoid arthritis with combination of methotrexate and Tripterygium wilfordii: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2017.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}